Cumberland Pharmaceuticals Inc. Investment-related Liabilities
Cumberland Pharmaceuticals Inc. (CPIX) had Investment-related Liabilities of $4.49 million as of 2026-03-31, per its 10-Q filed 2026-05-08.
Financial Statements › Balance Sheet › Liabilities
us-gaap:InvestmentRelatedLiabilities · last filed 2026-05-08
- 2026-03-31: Investment-related Liabilities $4.49M.
- 2025-12-31: Investment-related Liabilities $5.07M.
- 2024-12-31: Investment-related Liabilities $0.00.
| Period end | Investment-related Liabilities |
|---|---|
| 2026-03-31 | $4.49M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $5.07M 10-Q · filed 2026-05-08 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |